APA (7th ed.) Citation

J, V., I, D., K, C., E, P., E, W., FJ, B., . . . M, S. (2025). Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: An open-label, dose-escalation phase I/II study in non-small-cell lung cancer. ESMO open, 10(11), 105844. https://doi.org/10.1016/j.esmoop.2025.105844

Chicago Style (17th ed.) Citation

J, Vansteenkiste, et al. "Innovative Therapeutic Cancer Vaccine PDC∗lung01 with or Without Anti-PD-1: An Open-label, Dose-escalation Phase I/II Study in Non-small-cell Lung Cancer." ESMO Open 10, no. 11 (2025): 105844. https://doi.org/10.1016/j.esmoop.2025.105844.

MLA (9th ed.) Citation

J, Vansteenkiste, et al. "Innovative Therapeutic Cancer Vaccine PDC∗lung01 with or Without Anti-PD-1: An Open-label, Dose-escalation Phase I/II Study in Non-small-cell Lung Cancer." ESMO Open, vol. 10, no. 11, 2025, p. 105844, https://doi.org/10.1016/j.esmoop.2025.105844.